| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | face development | 1.19e-05 | 63 | 167 | 6 | GO:0060324 | |
| MousePheno | abnormal head shape | 1.23e-05 | 115 | 131 | 8 | MP:0011495 | |
| Domain | PH | KALRN RALGPS2 OBSCN PLEKHA4 GRB10 RASAL3 PLEKHA5 PLCG1 PLEKHO1 FGD6 | 1.69e-04 | 278 | 163 | 10 | SM00233 |
| Domain | PH_DOMAIN | KALRN RALGPS2 OBSCN PLEKHA4 GRB10 RASAL3 PLEKHA5 PLCG1 PLEKHO1 FGD6 | 1.74e-04 | 279 | 163 | 10 | PS50003 |
| Domain | PH_domain | KALRN RALGPS2 OBSCN PLEKHA4 GRB10 RASAL3 PLEKHA5 PLCG1 PLEKHO1 FGD6 | 1.80e-04 | 280 | 163 | 10 | IPR001849 |
| Domain | PH | KALRN RALGPS2 OBSCN PLEKHA4 GRB10 PLEKHA5 PLCG1 PLEKHO1 FGD6 | 1.87e-04 | 229 | 163 | 9 | PF00169 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 RAF1 ATXN2L SH3RF1 RALGPS2 C19orf47 GRB10 SPECC1 VIRMA RUSC2 NHSL1 ABLIM1 RESF1 KCNQ5 CSNK1D SYDE2 SVIL ARFGAP1 NAV2 PLEKHA5 GNAS PUM1 FGD6 WNK3 SAMD4A AHNAK2 | 1.32e-13 | 861 | 170 | 26 | 36931259 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | RAF1 EPPK1 TCOF1 CHD7 KMT2E NEDD9 GUCY1B2 RASAL3 EIF4ENIF1 PIAS3 TULP4 GLI2 ARID2 CAMTA1 SPEN PLEKHO1 PCNT | 4.87e-11 | 430 | 170 | 17 | 35044719 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 NDOR1 EPPK1 SETD1B SH3RF1 KALRN UBE4B MAPKAPK2 C19orf47 OBSCN GRB10 KIAA2013 PHC2 ITPR2 NHSL1 EIF4ENIF1 TULP4 NAV2 HMGXB3 PLCG1 PUM1 SPEN AHNAK2 MVB12B PCNT | 1.97e-10 | 1105 | 170 | 25 | 35748872 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TNIK TANC2 RAF1 TCOF1 MAPKAPK2 GRB10 MEF2A RUSC2 ABLIM1 HROB EIF4ENIF1 CEP78 CSNK1D WDR20 ARFGAP1 WDR89 CRYBG1 PLEKHA5 EIF3C GNAS PJA1 CTNNB1 PUM1 SAMD4A | 3.05e-10 | 1038 | 170 | 24 | 26673895 |
| Pubmed | TNIK SETD1B UBE4B GRB10 R3HDM2 VIRMA RUSC2 ABLIM1 KANK1 ASXL2 ANKRD12 CAMTA1 PUM1 SPEN PCNT | 1.83e-09 | 407 | 170 | 15 | 12693553 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | COL7A1 INCENP KALRN NBEAL1 ABCA13 NTRK2 SIDT1 MUC16 R3HDM2 ZBTB41 CHD7 SHROOM4 A2ML1 NAV2 CRYBG1 GNAS | 1.55e-08 | 552 | 170 | 16 | 10737800 |
| Pubmed | TANC2 SLC4A8 SH3RF1 COL27A1 GPRIN3 UBN2 KIAA2013 SHROOM4 TRIM66 FAT2 TULP4 ARID2 SS18L1 FBXO42 FGD6 | 2.36e-08 | 493 | 170 | 15 | 15368895 | |
| Pubmed | TNIK TANC2 ILF3 SLC4A8 TCOF1 KALRN NTRK2 CHD7 SPECC1L UBN2 VIRMA ABLIM1 SVIL KCNMA1 PLEKHA5 CTNNB1 SLC4A4 NIPBL WNK3 PCNT | 6.03e-08 | 963 | 170 | 20 | 28671696 | |
| Pubmed | HNRNPDL FAM168B RALGPS2 OBSCN ZBTB41 CHD7 UBN2 ZBTB24 RESF1 ARFGAP1 CRYBG1 HMGXB3 ASXL2 ANKRD12 PLCG1 ACCSL PJA1 CAMTA1 PUM1 WDFY1 PCNT | 8.84e-08 | 1084 | 170 | 21 | 11544199 | |
| Pubmed | VEZF1 AIMP1 R3HDM2 CHD7 UBN2 INO80D MEF2A EEF1D RESF1 EIF4ENIF1 ZNF608 ATXN7 GLI2 ARID2 SS18L1 SVIL WDR20 ARFGAP1 ASXL2 EIF3C PUM1 SPEN NIPBL RAI2 | 1.40e-07 | 1429 | 170 | 24 | 35140242 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HNRNPDL EPPK1 ILF3 TCOF1 C19orf47 SPECC1L SPECC1 RRP1 ITPR2 ABLIM1 EEF1D SVIL EIF3C GNAS CTNNB1 PUM1 SPEN NIPBL BAG6 PCNT | 1.61e-07 | 1024 | 170 | 20 | 24711643 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATXN2L SETD1B SH3RF1 TCOF1 C19orf47 E2F7 CHD7 UBN2 RESF1 ARID2 FBXO42 GNAS CTNNB1 SPEN PCNT | 2.31e-07 | 588 | 170 | 15 | 38580884 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HNRNPDL ATXN2L ILF3 TCOF1 UBE4B CHD7 VIRMA PHC2 ABLIM1 ATXN7 BRPF1 SVIL ARFGAP1 EIF3C SPEN NIPBL BAG6 | 2.90e-07 | 774 | 170 | 17 | 15302935 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TP53INP1 UBE4B AIMP1 MAPKAPK2 OBSCN GRB10 UBN2 MEF2A ABLIM1 KCNQ5 ZNF608 TULP4 ATXN7 CSNK1D MICAL2 GLI2 FBXO42 KCNMA1 ANKRD12 PLCG1 GNAS CAMTA1 PCNT GULP1 | 2.95e-07 | 1489 | 170 | 24 | 28611215 |
| Pubmed | ATXN2L KALRN R3HDM2 PHC2 OTX2 EIF4ENIF1 PTPRN ATXN7 PLEKHA5 PUM1 SPEN PLEKHO1 BAG6 PLSCR1 RAI2 | 3.52e-07 | 608 | 170 | 15 | 16713569 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | CHD7 KANK1 GZF1 GLI2 ARID2 SVIL WDR20 PLEKHA5 ACCSL CTNNB1 CAMTA1 PUM1 NIPBL WDFY1 | 4.47e-07 | 536 | 170 | 14 | 15840001 |
| Pubmed | CHD7 KANK1 GZF1 GLI2 ARID2 SVIL WDR20 PLEKHA5 ACCSL CTNNB1 CAMTA1 PUM1 NIPBL WDFY1 | 4.68e-07 | 538 | 170 | 14 | 10512203 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | IGSF8 ATXN2L VEZF1 TCOF1 UBE4B KMT2E ONECUT1 VIRMA RRP1 ZNF250 ABLIM1 EEF1D GZF1 PIAS3 ZNF608 MICAL2 GLI2 GNAS CTNNB1 BAG6 PLSCR1 | 4.89e-07 | 1203 | 170 | 21 | 29180619 |
| Pubmed | VEZF1 ZBTB41 ONECUT1 MEF2A CREM ZBTB24 ABLIM1 OTX2 PIAS3 ZIC5 ARID2 BRPF1 HMGXB3 ELK1 PLCG1 CTNNB1 LEF1 | 5.26e-07 | 808 | 170 | 17 | 20412781 | |
| Pubmed | TANC2 ROBO4 MXRA5 AIMP1 MUC16 CHD7 VIRMA ZNF251 GUCY1B2 ATXN7 ARID2 SS18L1 SPEN NIPBL AHNAK2 | 6.45e-07 | 638 | 170 | 15 | 31182584 | |
| Pubmed | 9.36e-07 | 153 | 170 | 8 | 10718198 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HNRNPDL ATXN2L EPPK1 ILF3 INCENP AIMP1 SPECC1L SPECC1 VIRMA PHC2 RRP1 ITPR2 ABLIM1 EEF1D CSNK1D SVIL CRYBG1 PLEKHA5 GNAS CTNNB1 SPEN | 9.88e-07 | 1257 | 170 | 21 | 36526897 |
| Pubmed | MAN2A1 VEZF1 CHD7 SPECC1L UBN2 SPECC1 VIRMA INO80D KIAA2013 PHC2 RRP1 GREB1L ABLIM1 GZF1 EIF4ENIF1 ATXN7 ARID2 WDR20 WDR89 CRYBG1 EIF3C SPEN NIPBL | 1.21e-06 | 1497 | 170 | 23 | 31527615 | |
| Pubmed | TANC2 ATXN2L SPECC1 RUSC2 ABLIM1 AMER2 ARFGAP1 PRRT3 KCNMA1 EIF3C CTNNB1 | 1.25e-06 | 347 | 170 | 11 | 17114649 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.39e-06 | 218 | 170 | 9 | 33378226 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | CHD7 UBN2 OTX2 RESF1 ZNF608 ARID2 SS18L1 ASXL2 CTNNB1 SPEN NIPBL | 1.40e-06 | 351 | 170 | 11 | 38297188 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.60e-06 | 18 | 170 | 4 | 18834073 | |
| Pubmed | 1.81e-06 | 225 | 170 | 9 | 12168954 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ILF3 UBN2 PDLIM4 ABLIM1 EEF1D RESF1 PIAS3 ZNF608 ATXN7 ARFGAP1 EIF3C AHNAK2 | 2.15e-06 | 444 | 170 | 12 | 34795231 |
| Pubmed | TANC2 RAF1 SH3RF1 RALGPS2 KIAA1549 R3HDM2 ABLIM1 EIF4ENIF1 PLEKHA5 CTNNB1 PUM1 SAMD4A | 2.25e-06 | 446 | 170 | 12 | 24255178 | |
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 16678815 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ATXN2L SH3RF1 SPECC1 NHSL1 ABLIM1 EEF1D CSNK1D SVIL NAV2 CRYBG1 PLEKHA5 CTNNB1 PLSCR1 | 4.67e-06 | 565 | 170 | 13 | 25468996 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TNIK RAF1 SLC4A8 RALGPS2 KIAA1549 SPECC1 AMER2 MICAL2 WDR20 NAV2 PLEKHA5 CTNNB1 FGD6 | 5.04e-06 | 569 | 170 | 13 | 30639242 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | ATXN2L EPPK1 TCOF1 EEF1D EIF4ENIF1 WDR20 ARFGAP1 PLEKHA5 AHNAK2 | 5.19e-06 | 256 | 170 | 9 | 33397691 |
| Pubmed | IGSF8 TANC2 RAF1 ATXN2L ILF3 KALRN KIAA1549 SPECC1L SPECC1 VIRMA ITPR2 NHSL1 ABLIM1 EEF1D CSNK1D MICAL2 SVIL PLEKHA5 EIF3C CTNNB1 SLC4A4 | 7.40e-06 | 1431 | 170 | 21 | 37142655 | |
| Pubmed | ATXN2L ILF3 TCOF1 KALRN GRB10 ARFGAP1 NAV2 PLEKHA5 EIF3C SPEN NIPBL BAG6 | 7.63e-06 | 503 | 170 | 12 | 16964243 | |
| Pubmed | COL12A1 SH3RF1 NBEAL1 MAPKAPK2 ADNP2 HSF5 NHSL1 ABLIM1 EEF1D KANK1 SVIL ASXL2 FGD6 SAMD4A | 8.21e-06 | 689 | 170 | 14 | 36543142 | |
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 35678316 | ||
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 20960542 | ||
| Pubmed | 1.08e-05 | 101 | 170 | 6 | 10997877 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 1.08e-05 | 101 | 170 | 6 | 24613305 | |
| Pubmed | SH3RF1 VEZF1 ONECUT1 MEF2A CREM PDLIM4 ABLIM1 OTX2 PIAS3 GLI2 BRPF1 HMGXB3 PJA1 LEF1 | 1.13e-05 | 709 | 170 | 14 | 22988430 | |
| Pubmed | TNIK RAF1 ATXN2L ILF3 VEZF1 TCOF1 AIMP1 CHD7 SPECC1L VIRMA PHC2 RRP1 EEF1D GZF1 CEP78 CSNK1D SVIL GNAS CTNNB1 MUC5AC | 1.35e-05 | 1371 | 170 | 20 | 36244648 | |
| Pubmed | 1.58e-05 | 371 | 170 | 10 | 15747579 | ||
| Pubmed | HNRNPDL RAF1 EPPK1 ILF3 TCOF1 AIMP1 SPECC1L SPECC1 MICAL2 ARID2 SVIL NAV2 CTNNB1 | 1.59e-05 | 634 | 170 | 13 | 34591612 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24145616 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26481038 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28152519 | ||
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 2.38e-05 | 2 | 170 | 2 | 18475301 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22220206 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 21075118 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 20360943 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22507326 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24374017 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 10585452 | ||
| Pubmed | Expression of tyrosine kinase receptor B in eutopic endometrium of women with adenomyosis. | 2.38e-05 | 2 | 170 | 2 | 21079983 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22126602 | ||
| Pubmed | Phospholipase Cγ1 represses colorectal cancer growth by inhibiting the Wnt/β-catenin signaling axis. | 2.38e-05 | 2 | 170 | 2 | 34509721 | |
| Pubmed | Physiological role of β-catenin/TCF signaling in neurons of the adult brain. | 2.38e-05 | 2 | 170 | 2 | 23377854 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17851558 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 21744004 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23544943 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15936755 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28027119 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27067790 | ||
| Pubmed | Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice. | 2.38e-05 | 2 | 170 | 2 | 19158956 | |
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 2.38e-05 | 2 | 170 | 2 | 24722639 | |
| Pubmed | Functional interaction of beta-catenin with the transcription factor LEF-1. | 2.38e-05 | 2 | 170 | 2 | 8757136 | |
| Pubmed | Disruption of TrkB-mediated phospholipase Cgamma signaling inhibits limbic epileptogenesis. | 2.38e-05 | 2 | 170 | 2 | 20445044 | |
| Pubmed | Prolactin expression is induced in Jurkat T-cells by beta-catenin LEF-1, AP-1 and cAMP. | 2.38e-05 | 2 | 170 | 2 | 17240357 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18782111 | ||
| Pubmed | Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. | 2.38e-05 | 2 | 170 | 2 | 8892228 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17314919 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16968744 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16571757 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 35960138 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 29736797 | ||
| Pubmed | Overactive beta-catenin signaling causes testicular sertoli cell tumor development in the mouse. | 2.38e-05 | 2 | 170 | 2 | 19553598 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 11986304 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24658583 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22106277 | ||
| Pubmed | Recurrent SPECC1L-NTRK fusions in pediatric sarcoma and brain tumors. | 2.38e-05 | 2 | 170 | 2 | 33144287 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 11854293 | ||
| Pubmed | Interactions between β-catenin and the HSlo potassium channel regulates HSlo surface expression. | 2.38e-05 | 2 | 170 | 2 | 22194818 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 37028765 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12181329 | ||
| Pubmed | Deficiency of the cytoskeletal protein SPECC1L leads to oblique facial clefting. | 2.38e-05 | 2 | 170 | 2 | 21703590 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28300597 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26526617 | ||
| Pubmed | TNIK signaling imprints CD8+ T cell memory formation early after priming. | 2.38e-05 | 2 | 170 | 2 | 32242021 | |
| Pubmed | PLCγ-activated signalling is essential for TrkB mediated sensory neuron structural plasticity. | 2.38e-05 | 2 | 170 | 2 | 20932311 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22020335 | ||
| Pubmed | 2.76e-05 | 396 | 170 | 10 | 26687479 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.88e-05 | 398 | 170 | 10 | 35016035 | |
| Pubmed | 3.02e-05 | 73 | 170 | 5 | 22094256 | ||
| Pubmed | HNRNPDL RAF1 ILF3 MAPKAPK2 ABLIM1 SVIL WDR20 EIF3C GNAS CTNNB1 | 3.07e-05 | 401 | 170 | 10 | 25852190 | |
| Pubmed | Effects of Wnt1 signaling on proliferation in the developing mid-/hindbrain region. | 3.17e-05 | 13 | 170 | 3 | 15121182 | |
| Pubmed | TANC2 RAF1 TCOF1 ADNP2 KIAA1549 INO80D ELL3 TRIM66 RESF1 RASAL3 EIF4ENIF1 ZNF608 ATXN7 ARID2 BRPF1 SS18L1 WDR20 | 3.65e-05 | 1116 | 170 | 17 | 31753913 | |
| Pubmed | Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. | 4.01e-05 | 14 | 170 | 3 | 24076664 | |
| Pubmed | IGSF8 MAN2A1 MUC16 FAT2 ADGRG2 A2ML1 GNAS CTNNB1 MUC4 MUC5AC | 4.26e-05 | 417 | 170 | 10 | 19199708 | |
| Interaction | YWHAH interactions | TANC2 RAF1 ATXN2L EPPK1 ILF3 SH3RF1 RALGPS2 C19orf47 PLEKHA4 GRB10 R3HDM2 SPECC1L SPECC1 VIRMA RUSC2 NHSL1 ABLIM1 KANK1 RESF1 KCNQ5 CSNK1D SYDE2 SVIL WDR20 ARFGAP1 KCNMA1 NAV2 PLEKHA5 PUM1 FGD6 WNK3 SAMD4A AHNAK2 PCNT | 1.58e-11 | 1102 | 165 | 34 | int:YWHAH |
| Interaction | YWHAZ interactions | TANC2 RAF1 ATXN2L SH3RF1 MAPKAPK2 RALGPS2 PLEKHA4 GRB10 R3HDM2 SPECC1 VIRMA RUSC2 NHSL1 ABLIM1 KANK1 RASAL3 KCNQ5 CSF2RB CSNK1D SYDE2 SVIL WDR20 KCNMA1 NAV2 PLEKHA5 ASXL2 CTNNB1 PUM1 FGD6 SAMD4A PCNT | 8.93e-08 | 1319 | 165 | 31 | int:YWHAZ |
| Interaction | YWHAQ interactions | TANC2 RAF1 ATXN2L EPPK1 ILF3 SH3RF1 RALGPS2 C19orf47 PLEKHA4 R3HDM2 SPECC1L SPECC1 VIRMA RUSC2 NHSL1 ABLIM1 KANK1 KCNQ5 SYDE2 SVIL WDR20 KCNMA1 NAV2 PLEKHA5 CTNNB1 PUM1 FGD6 SAMD4A | 1.14e-07 | 1118 | 165 | 28 | int:YWHAQ |
| Interaction | SFN interactions | TNIK TANC2 RAF1 ATXN2L SH3RF1 RALGPS2 GRB10 SPECC1 VIRMA RUSC2 ABLIM1 KCNQ5 SVIL NAV2 PLEKHA5 EIF3C CTNNB1 PUM1 FGD6 SAMD4A AHNAK2 | 2.44e-07 | 692 | 165 | 21 | int:SFN |
| Interaction | YWHAG interactions | TANC2 RAF1 ATXN2L SH3RF1 RALGPS2 C19orf47 PLEKHA4 GRB10 R3HDM2 SPECC1L SPECC1 VIRMA RUSC2 NHSL1 ABLIM1 KANK1 KCNQ5 CEP78 SYDE2 SVIL WDR20 KCNMA1 NAV2 PLEKHA5 GNAS PUM1 FGD6 SAMD4A AHNAK2 | 3.16e-07 | 1248 | 165 | 29 | int:YWHAG |
| Interaction | TOP3B interactions | TANC2 NDOR1 EPPK1 SETD1B SH3RF1 KALRN UBE4B AIMP1 MAPKAPK2 C19orf47 OBSCN PLEKHA4 GRB10 R3HDM2 KIAA2013 PHC2 ITPR2 ZNF250 NHSL1 EIF4ENIF1 TULP4 SVIL NAV2 HMGXB3 PLCG1 GNAS PUM1 SPEN AHNAK2 MVB12B PCNT | 9.50e-07 | 1470 | 165 | 31 | int:TOP3B |
| Interaction | YWHAB interactions | TANC2 RAF1 ATXN2L SH3RF1 RALGPS2 PLEKHA4 R3HDM2 SPECC1 VIRMA RUSC2 NHSL1 ABLIM1 KANK1 KCNQ5 SYDE2 SVIL WDR20 KCNMA1 NAV2 PLEKHA5 PUM1 FGD6 SAMD4A AHNAK2 | 2.75e-06 | 1014 | 165 | 24 | int:YWHAB |
| Interaction | YWHAE interactions | TANC2 RAF1 ATXN2L ILF3 SH3RF1 RALGPS2 PLEKHA4 GRB10 R3HDM2 SPECC1 VIRMA RUSC2 ABLIM1 KANK1 RASAL3 KCNQ5 SYDE2 SVIL WDR20 KCNMA1 NAV2 PLEKHA5 ASXL2 CTNNB1 PUM1 FGD6 SAMD4A | 3.75e-06 | 1256 | 165 | 27 | int:YWHAE |
| Interaction | PRRC2B interactions | TNIK RAF1 PLEKHA4 R3HDM2 VIRMA TRIM66 EEF1D EIF4ENIF1 FBXO42 EIF3C PUM1 | 1.22e-05 | 265 | 165 | 11 | int:PRRC2B |
| Interaction | CAPZA2 interactions | RAF1 UBE4B PLEKHA4 SPECC1L SPECC1 VIRMA ITPR2 ABLIM1 FBXO42 SVIL CRYBG1 ASXL2 CTNNB1 PLEKHO1 | 1.27e-05 | 430 | 165 | 14 | int:CAPZA2 |
| Interaction | SIPA1L1 interactions | TNIK TANC2 KALRN RALGPS2 PLEKHA4 VIRMA TRIM66 PLEKHA5 CTNNB1 | 1.37e-05 | 174 | 165 | 9 | int:SIPA1L1 |
| Interaction | TNK1 interactions | 1.40e-05 | 38 | 165 | 5 | int:TNK1 | |
| Interaction | NR3C1 interactions | HNRNPDL TANC2 RAF1 ROBO4 MXRA5 AIMP1 PLEKHA4 MUC16 CHD7 ONECUT1 VIRMA ZNF251 GUCY1B2 ATXN7 ARID2 SS18L1 FBXO42 SVIL CTNNB1 SPEN NIPBL AHNAK2 | 1.55e-05 | 974 | 165 | 22 | int:NR3C1 |
| Interaction | CBX3 interactions | HNRNPDL RAF1 INCENP VEZF1 TCOF1 PLEKHA4 ADNP2 CHD7 UBN2 VIRMA ZNF250 TRIM66 ARID2 ASXL2 CTNNB1 SPEN NIPBL | 2.35e-05 | 646 | 165 | 17 | int:CBX3 |
| Interaction | CTNNB1 interactions | TNIK TANC2 RAF1 ATXN2L FLT3 ILF3 PLEKHA4 GRB10 SPECC1L SPECC1 VIRMA NHSL1 EEF1D CEP78 CSNK1D FBXO42 SVIL PLEKHA5 ELK1 ASXL2 CTNNB1 LEF1 | 2.66e-05 | 1009 | 165 | 22 | int:CTNNB1 |
| Interaction | HNF1B interactions | 2.75e-05 | 190 | 165 | 9 | int:HNF1B | |
| Interaction | SYNPO interactions | 2.99e-05 | 192 | 165 | 9 | int:SYNPO | |
| Interaction | CTBP1 interactions | TNIK MAN2A1 PLEKHA4 E2F7 VIRMA EEF1D RESF1 EIF4ENIF1 KCNMA1 CTNNB1 SPEN BAG6 RAI2 | 3.11e-05 | 406 | 165 | 13 | int:CTBP1 |
| Interaction | KDR interactions | 3.35e-05 | 150 | 165 | 8 | int:KDR | |
| Interaction | CRX interactions | 4.79e-05 | 254 | 165 | 10 | int:CRX | |
| Interaction | SEC16A interactions | RAF1 PLEKHA4 R3HDM2 VIRMA TRIM66 EEF1D EIF4ENIF1 CSNK1D FBXO42 PLEKHA5 CTNNB1 PUM1 WNK3 | 5.09e-05 | 426 | 165 | 13 | int:SEC16A |
| Interaction | TNIK interactions | TNIK TANC2 RAF1 KALRN NTRK2 PLEKHA4 UBN2 VIRMA ABLIM1 KCNMA1 PLEKHA5 CTNNB1 | 7.39e-05 | 381 | 165 | 12 | int:TNIK |
| Interaction | BICC1 interactions | 7.61e-05 | 28 | 165 | 4 | int:BICC1 | |
| Interaction | EGR2 interactions | 8.45e-05 | 171 | 165 | 8 | int:EGR2 | |
| Interaction | LYN interactions | TNIK FLT3 SH3RF1 INCENP PLEKHA4 GPRIN3 SPECC1 VIRMA NEDD9 ABLIM1 CSF2RB SVIL WDR20 PLEKHA5 PLCG1 CTNNB1 AHNAK2 | 9.01e-05 | 720 | 165 | 17 | int:LYN |
| Interaction | HNF4A interactions | 9.28e-05 | 275 | 165 | 10 | int:HNF4A | |
| Interaction | ERG interactions | 9.52e-05 | 223 | 165 | 9 | int:ERG | |
| Interaction | CDH10 interactions | 1.12e-04 | 12 | 165 | 3 | int:CDH10 | |
| Interaction | CDCA8 interactions | 1.14e-04 | 133 | 165 | 7 | int:CDCA8 | |
| Interaction | ELP1 interactions | 1.30e-04 | 182 | 165 | 8 | int:ELP1 | |
| Interaction | ANKRD36B interactions | 1.31e-04 | 60 | 165 | 5 | int:ANKRD36B | |
| Interaction | FMR1 interactions | TNIK RAF1 ATXN2L ILF3 TCOF1 PLEKHA4 CHD7 VIRMA EIF4ENIF1 KCNMA1 CTNNB1 PUM1 NIPBL PCNT | 1.37e-04 | 536 | 165 | 14 | int:FMR1 |
| Interaction | KALRN interactions | 1.39e-04 | 96 | 165 | 6 | int:KALRN | |
| Interaction | CLASP1 interactions | 1.43e-04 | 138 | 165 | 7 | int:CLASP1 | |
| Interaction | MYH9 interactions | RAF1 TCOF1 PLEKHA4 SPECC1L SPECC1 VIRMA ITPR2 NEDD9 ABLIM1 EEF1D OVGP1 CIAO3 SVIL EIF3C PLCG1 GNAS CTNNB1 | 1.57e-04 | 754 | 165 | 17 | int:MYH9 |
| Interaction | SPTBN1 interactions | TNIK RAF1 KALRN AIMP1 PLEKHA4 VIRMA ZNF251 SVIL NAV2 PLEKHA5 PJA1 PCNT | 1.88e-04 | 421 | 165 | 12 | int:SPTBN1 |
| Interaction | ACTG1P20 interactions | 1.99e-04 | 3 | 165 | 2 | int:ACTG1P20 | |
| Interaction | KIAA1671 interactions | 2.02e-04 | 194 | 165 | 8 | int:KIAA1671 | |
| Interaction | NRAS interactions | TNIK RAF1 SLC4A8 RALGPS2 SPECC1 PDLIM4 AMER2 WDR20 ARFGAP1 NAV2 PLEKHA5 GNAS CTNNB1 LEF1 PLEKHO1 PLSCR1 | 2.08e-04 | 699 | 165 | 16 | int:NRAS |
| Interaction | NUP188 interactions | 2.21e-04 | 148 | 165 | 7 | int:NUP188 | |
| Interaction | SYNGAP1 interactions | 2.27e-04 | 307 | 165 | 10 | int:SYNGAP1 | |
| Interaction | MON2 interactions | 2.30e-04 | 149 | 165 | 7 | int:MON2 | |
| Interaction | FYN interactions | RAF1 ILF3 SLC4A8 KALRN NTRK2 PLEKHA4 GRB10 NEDD9 CSF2RB ANKRD12 PLCG1 CTNNB1 | 2.33e-04 | 431 | 165 | 12 | int:FYN |
| Interaction | MITF interactions | 2.38e-04 | 68 | 165 | 5 | int:MITF | |
| GeneFamily | CD molecules|Mucins | 9.16e-06 | 21 | 117 | 4 | 648 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.88e-04 | 206 | 117 | 7 | 682 | |
| GeneFamily | Fibronectin type III domain containing | 6.09e-04 | 160 | 117 | 6 | 555 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 2.25e-06 | 176 | 169 | 9 | M39223 | |
| Coexpression | PEREZ_TP53_TARGETS | MXRA5 GLDN EPPK1 TP53INP1 KALRN ABCA13 COL27A1 SIDT1 OBSCN KIAA1549 NPIPB3 ELL3 MEF2A EDNRA NEDD9 ARID2 BRPF1 WDR20 PRRT3 GNAS CAMTA1 MUC5AC AHNAK2 | 3.04e-06 | 1201 | 169 | 23 | M4391 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | FLT3 GLDN TP53INP1 GPRIN3 CHD7 CREM ITPR2 ABLIM1 ZNF608 ATXN7 ASXL2 PLCG1 LEF1 NIPBL | 4.65e-06 | 498 | 169 | 14 | M1741 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | 5.14e-06 | 104 | 169 | 7 | M45682 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | FLT3 GLDN TP53INP1 GPRIN3 CHD7 CREM ITPR2 ABLIM1 ZNF608 ATXN7 ASXL2 PLCG1 LEF1 NIPBL | 5.70e-06 | 507 | 169 | 14 | MM1030 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 NDOR1 TP53INP1 KALRN NBEAL1 COL27A1 RALGPS2 KIAA1549 SPECC1 ITPR2 NHSL1 SSC5D ABLIM1 KANK1 CEP78 TULP4 SVIL NAV2 TMEM108 ANKRD12 WDFY1 | 9.15e-06 | 1102 | 169 | 21 | M2369 |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | 1.03e-05 | 161 | 169 | 8 | M7728 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 NDOR1 TP53INP1 KALRN NBEAL1 COL27A1 RALGPS2 KIAA1549 SPECC1 ITPR2 NHSL1 SSC5D ABLIM1 KANK1 CEP78 TULP4 SVIL NAV2 TMEM108 ANKRD12 WDFY1 | 1.23e-05 | 1124 | 169 | 21 | MM1070 |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP | 1.59e-05 | 171 | 169 | 8 | M6316 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D4 | 2.57e-05 | 54 | 169 | 5 | M15468 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP | 4.39e-05 | 197 | 169 | 8 | M4504 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN | 4.39e-05 | 197 | 169 | 8 | M7921 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN | 4.88e-05 | 200 | 169 | 8 | M6247 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 4.88e-05 | 200 | 169 | 8 | M6513 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP | 5.79e-05 | 151 | 169 | 7 | M6760 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | SH3RF1 CHD7 SPECC1 KIAA2013 RUSC2 GLMP TRIM66 YIPF1 CSNK1D MICAL2 SYDE2 FGD6 PLSCR1 SAMD4A MVB12B | 1.04e-04 | 746 | 169 | 15 | M40863 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN | EPPK1 ABCA13 RALGPS2 MUC16 ATP10B ELL3 ABLIM1 PIAS3 MUC4 AHNAK2 | 1.17e-04 | 358 | 169 | 10 | M12671 |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN | 1.26e-04 | 171 | 169 | 7 | M6321 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.16e-08 | 195 | 169 | 9 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.72e-08 | 197 | 169 | 9 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.65e-08 | 200 | 169 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.92e-07 | 182 | 169 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-07 | 187 | 169 | 8 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-07 | 187 | 169 | 8 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-07 | 188 | 169 | 8 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-07 | 189 | 169 | 8 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-07 | 189 | 169 | 8 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.38e-07 | 192 | 169 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.67e-07 | 193 | 169 | 8 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.67e-07 | 193 | 169 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.95e-07 | 197 | 169 | 8 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4|Liver / Manually curated celltypes from each tissue | 8.95e-07 | 197 | 169 | 8 | 4891111894b741555f549deec6af8006376d9358 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-07 | 197 | 169 | 8 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.95e-07 | 197 | 169 | 8 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.95e-07 | 197 | 169 | 8 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.95e-07 | 197 | 169 | 8 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.95e-07 | 197 | 169 | 8 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.95e-07 | 197 | 169 | 8 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-06 | 200 | 169 | 8 | 410b1a31de21c57d87ca2104f61cf4a7d4dd2f30 | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.42e-06 | 166 | 169 | 7 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.42e-06 | 166 | 169 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.70e-06 | 168 | 169 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 169 | 169 | 7 | 2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-06 | 170 | 169 | 7 | 8e9b5f7bfb61f8d84d0b17fb0c191da4dabad63d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-06 | 173 | 169 | 7 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-06 | 175 | 169 | 7 | f949613ee45f5d950578c512d197716855118d18 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 5.22e-06 | 177 | 169 | 7 | eb87ea93e36a8f97442ec8515f658ee61932dc0f | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-06 | 177 | 169 | 7 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-06 | 178 | 169 | 7 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-06 | 179 | 169 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.04e-06 | 181 | 169 | 7 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.50e-06 | 183 | 169 | 7 | 41ae679e7332fcafa9101e62a4a910ebae63e87c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.73e-06 | 184 | 169 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 6.73e-06 | 184 | 169 | 7 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 6.73e-06 | 184 | 169 | 7 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.73e-06 | 184 | 169 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.97e-06 | 185 | 169 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.97e-06 | 185 | 169 | 7 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 6.97e-06 | 185 | 169 | 7 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.22e-06 | 186 | 169 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-06 | 187 | 169 | 7 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.75e-06 | 188 | 169 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 8.02e-06 | 189 | 169 | 7 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 8.02e-06 | 189 | 169 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.02e-06 | 189 | 169 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 8.30e-06 | 190 | 169 | 7 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 8.59e-06 | 191 | 169 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.89e-06 | 192 | 169 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-06 | 192 | 169 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 9.19e-06 | 193 | 169 | 7 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-06 | 194 | 169 | 7 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 9.51e-06 | 194 | 169 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 9.51e-06 | 194 | 169 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-06 | 194 | 169 | 7 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | Fibroblast-B_(Myofibroblast)|World / shred on cell class and cell subclass (v4) | 9.83e-06 | 195 | 169 | 7 | a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.83e-06 | 195 | 169 | 7 | 2414b158dc7bdec43a9671544bfb7ffc5f5168fd | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 9.83e-06 | 195 | 169 | 7 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.83e-06 | 195 | 169 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.83e-06 | 195 | 169 | 7 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 196 | 169 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 196 | 169 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 196 | 169 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-05 | 196 | 169 | 7 | faa39c567f24403e511b240c1d1a654ffadd8473 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 196 | 169 | 7 | 7d5eaed189aa6116f3799be010139fb675ec65e0 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 196 | 169 | 7 | 9d7b631f24a19a7dc7a28f28525d4019fc8fcf8a | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-05 | 197 | 169 | 7 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-05 | 197 | 169 | 7 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.05e-05 | 197 | 169 | 7 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 197 | 169 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 197 | 169 | 7 | 7d97c2d51a543c02d679e9257b22d0581e73a11d | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.05e-05 | 197 | 169 | 7 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 197 | 169 | 7 | 671d6b5effbac2dd71d18f48d23c523738db1828 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.09e-05 | 198 | 169 | 7 | 58f208b76cb0adcecdf632d92f92833a06f9bf71 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-05 | 198 | 169 | 7 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-05 | 198 | 169 | 7 | 8a7897d98f5296745d9005a7cd777f0a2f78000d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 198 | 169 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-05 | 199 | 169 | 7 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-05 | 199 | 169 | 7 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-05 | 199 | 169 | 7 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.12e-05 | 199 | 169 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-05 | 199 | 169 | 7 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-05 | 199 | 169 | 7 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-05 | 199 | 169 | 7 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 169 | 7 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | severe-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-05 | 200 | 169 | 7 | f74bdabadca8ad6dae1b6e6812c66325aac50db0 | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.47e-05 | 138 | 169 | 6 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-05 | 152 | 169 | 6 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-05 | 152 | 169 | 6 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-05 | 155 | 169 | 6 | 98d8432739965dd1ab77c899cb6321f7f05eaa46 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.50e-05 | 161 | 169 | 6 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| Disease | Pilomyxoid astrocytoma | 5.49e-06 | 7 | 161 | 3 | C1519086 | |
| Disease | stroke | 1.48e-05 | 144 | 161 | 7 | EFO_0000712 | |
| Disease | Congenital small ears | 7.39e-05 | 41 | 161 | 4 | C0152423 | |
| Disease | keratoconjunctivitis (is_marker_for) | 8.84e-05 | 3 | 161 | 2 | DOID:9368 (is_marker_for) | |
| Disease | Mandibulofacial Dysostosis | 1.76e-04 | 4 | 161 | 2 | C0242387 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 2.93e-04 | 5 | 161 | 2 | DOID:3030 (is_marker_for) | |
| Disease | Mandibulofacial dysostosis | 2.93e-04 | 5 | 161 | 2 | cv:CN004722 | |
| Disease | Disease Exacerbation | 3.01e-04 | 165 | 161 | 6 | C0235874 | |
| Disease | complement factor H-related protein 3 measurement | 3.42e-04 | 169 | 161 | 6 | EFO_0600056 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 3.78e-04 | 26 | 161 | 3 | EFO_0007870 | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.20e-04 | 64 | 161 | 4 | DOID:4947 (is_marker_for) | |
| Disease | Pituitary Hormone Deficiency, Combined, 1 | 4.37e-04 | 6 | 161 | 2 | C2751608 | |
| Disease | Child Development Disorders, Specific | 5.25e-04 | 29 | 161 | 3 | C0085997 | |
| Disease | Child Development Deviations | 5.25e-04 | 29 | 161 | 3 | C0085996 | |
| Disease | Developmental Disabilities | 5.81e-04 | 30 | 161 | 3 | C0008073 | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 6.10e-04 | 7 | 161 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | common bile duct neoplasm (is_marker_for) | 8.11e-04 | 8 | 161 | 2 | DOID:4608 (is_marker_for) | |
| Disease | Intellectual Disability | 8.16e-04 | 447 | 161 | 9 | C3714756 | |
| Disease | dry eye syndrome (is_marker_for) | 1.29e-03 | 10 | 161 | 2 | DOID:10140 (is_marker_for) | |
| Disease | cancer antigen 125 measurement | 1.29e-03 | 10 | 161 | 2 | EFO_0010603 | |
| Disease | Adrenal Gland Neoplasms | 1.58e-03 | 11 | 161 | 2 | C0001624 | |
| Disease | Adrenal Cancer | 1.58e-03 | 11 | 161 | 2 | C0750887 | |
| Disease | Craniofacial Abnormalities | 1.69e-03 | 156 | 161 | 5 | C0376634 | |
| Disease | Colorectal Carcinoma | COL7A1 TCOF1 KALRN ABCA13 OBSCN AMER2 OVGP1 KCNQ5 GNAS CTNNB1 LEF1 | 1.70e-03 | 702 | 161 | 11 | C0009402 |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.88e-03 | 12 | 161 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | UBE4B ITPR2 NEDD9 CSF2RB GLI2 FBXO42 A2ML1 KCNMA1 TMEM108 JHY | 2.20e-03 | 619 | 161 | 10 | EFO_0003923, EFO_0004531 |
| Disease | pancreatic cancer (is_marker_for) | 2.31e-03 | 101 | 161 | 4 | DOID:1793 (is_marker_for) | |
| Disease | glycodeoxycholate measurement | 2.58e-03 | 14 | 161 | 2 | EFO_0010493 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 2.58e-03 | 14 | 161 | 2 | DOID:3969 (is_marker_for) | |
| Disease | Tourette syndrome | 2.59e-03 | 50 | 161 | 3 | EFO_0004895 | |
| Disease | neutrophil measurement | 2.93e-03 | 177 | 161 | 5 | EFO_0803548 | |
| Disease | obsolete_red blood cell distribution width | FLT3 SETD1B KALRN C19orf47 R3HDM2 ZBTB24 PDLIM4 RESF1 ATXN7 WDR20 CRYBG1 ASXL2 ANKRD12 MUC4 WNK3 WDFY1 | 2.93e-03 | 1347 | 161 | 16 | EFO_0005192 |
| Disease | anemia (implicated_via_orthology) | 2.97e-03 | 15 | 161 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Malignant mesothelioma | 3.05e-03 | 109 | 161 | 4 | C0345967 | |
| Disease | ovarian cancer (is_implicated_in) | 3.58e-03 | 56 | 161 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 3.62e-03 | 268 | 161 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | otitis media (biomarker_via_orthology) | 3.81e-03 | 17 | 161 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | body weight | ATXN2L SH3RF1 NBEAL1 NTRK2 E2F7 GRB10 CHD7 VIRMA PHC2 TRIM66 KCNQ5 TULP4 PTPRN GNAS NIPBL | 3.90e-03 | 1261 | 161 | 15 | EFO_0004338 |
| Disease | 4-ethylphenylsulfate measurement | 4.27e-03 | 18 | 161 | 2 | EFO_0021148 | |
| Disease | Hemangiosarcoma | 4.27e-03 | 18 | 161 | 2 | C0018923 | |
| Disease | testosterone measurement | RAF1 ATXN2L TMEM176B RALGPS2 R3HDM2 CHD7 ONECUT1 NEDD9 SHROOM4 KCNQ5 ZIC5 PLCG1 SPOCD1 LEF1 JHY | 4.31e-03 | 1275 | 161 | 15 | EFO_0004908 |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 4.76e-03 | 19 | 161 | 2 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 4.76e-03 | 19 | 161 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 4.76e-03 | 19 | 161 | 2 | C1275081 | |
| Disease | Costello syndrome (disorder) | 4.76e-03 | 19 | 161 | 2 | C0587248 | |
| Disease | acne | 4.96e-03 | 125 | 161 | 4 | EFO_0003894 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 4.98e-03 | 63 | 161 | 3 | DOID:0050866 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSHRSDTLPVPSGQR | 1 | Q4AC99 | |
| SPVGSMQALRPSAQH | 61 | P84996 | |
| SHPVVHQQPSRSEMP | 621 | Q8N7J2 | |
| EMVSSNIRHSPPGER | 506 | Q9Y6Y1 | |
| SVTSTMPNVAPAAIH | 106 | P19419 | |
| MDSIPAPSSVQGHNL | 116 | Q9HB65 | |
| PMQETASSHEQPASG | 66 | Q14511 | |
| RMITNSLNHDSPPST | 141 | Q8N9M1 | |
| MIHRSTSQGSINSPV | 446 | O14639 | |
| GQEPTPSNIRMATHT | 796 | P46379 | |
| PSGTPLHANSMVSEN | 81 | Q12904 | |
| SELTPQTDSMPTQLH | 691 | Q9H116 | |
| IDPMPQGHSSQRSII | 646 | A8K2U0 | |
| QSETISSPMPQTHVS | 321 | Q8IZP9 | |
| PSSSHQMLSEIRPQA | 471 | Q68CP9 | |
| TAPAAAVSPMQRHST | 856 | Q5M775 | |
| SPMQRHSISGPISTS | 881 | Q69YQ0 | |
| SLMPVVHHTSPQNAG | 1641 | Q86UQ4 | |
| TLPSMVHRVSGQPQS | 141 | Q8N6T3 | |
| HSPQAESMITSIGNP | 296 | Q6ZMI3 | |
| THQPTNLVLPSNGSM | 51 | P25101 | |
| GHPQMTSTVSNPPKE | 561 | Q5JTW2 | |
| NTVMDSPVHLEPSSQ | 1396 | Q6UB98 | |
| QSPSMAPSLRHSVQQ | 241 | Q9P2D1 | |
| GHRATAPQTQHVSPM | 121 | P29692 | |
| TIPASQAMNPSSHGQ | 1366 | Q76L83 | |
| QRSMGHRESSQPPVA | 521 | O94823 | |
| NPRMLTSGSHPQAIV | 821 | Q8WWM7 | |
| LNVSQRTPTTHAMSP | 326 | Q04844 | |
| AGQSHMTLVSSPLPV | 326 | Q6IQ32 | |
| NLSHSMAGISVPPIQ | 571 | Q6ZS30 | |
| PQQMIISRHLPSVSS | 621 | Q92617 | |
| HPQQTSFIMASTGQP | 471 | Q9Y2K5 | |
| PNVHMVSTTLPVDSR | 261 | P04049 | |
| SHQEPMVSTQPAPRS | 51 | Q86YV0 | |
| PIHMQVEGSSAPELN | 91 | Q9Y5P3 | |
| SIDLQSQMEPRTHPT | 206 | Q9BQ51 | |
| RTPVTGSHQVPTMTL | 2431 | Q14571 | |
| RTARQHPPADSSVTM | 106 | O14979 | |
| PQPSIEEARQTMHSL | 1676 | Q9HCM3 | |
| SDVNSKQGMSRHPPA | 176 | Q9UJU2 | |
| NSLIPVTHSPMDGRS | 1376 | Q6ZRR7 | |
| SMRHPPEQTNGVHTP | 526 | Q6P3S6 | |
| MDPSNTTPQAGIHSA | 4991 | Q8WXI7 | |
| PSSSPMLDRHTSQQI | 596 | Q99102 | |
| GMQIPSTQFDAAHPT | 106 | P35222 | |
| AAVLPQTAHSTSPMR | 561 | Q16849 | |
| MQRASPHSQSPGSAQ | 341 | Q96QS6 | |
| MQSTKVPQTPLHTSR | 326 | P49137 | |
| NSPVHGMLRQPSITT | 981 | Q12791 | |
| SNVPRGQPSDMVNDH | 341 | Q6NUN7 | |
| LMHSPPGTQNISEIN | 1116 | Q16706 | |
| QHVTQLMSTEPLPRT | 181 | Q9NQS7 | |
| SPTMHSQATQVPISQ | 706 | Q9NR82 | |
| NTAPETVPSHAGMAE | 166 | Q12766 | |
| PVRHVQEGSRATMPQ | 816 | Q5SYE7 | |
| SQMNASHPETNLPVG | 6 | O15162 | |
| SGPSQHTLTVMVRDQ | 1516 | Q9NYQ8 | |
| HTANTSPRPVSGMER | 351 | P48730 | |
| EQHLTPTSAGMVPIN | 231 | Q9UBC0 | |
| SMPSVASHTRGPEQQ | 1086 | O60229 | |
| TTHPQMQQASVSSPI | 196 | Q6KC79 | |
| SGISTPVTNVSPMHL | 246 | Q14678 | |
| TPGNTMHFENISSPE | 941 | Q8IZD2 | |
| DIMVSAPQTPTHGAL | 416 | Q8N3J3 | |
| TEVAPDPTTMGNRHR | 1286 | P10070 | |
| PTGAQTQTTFTTHMP | 1696 | P98088 | |
| DSSMLSPPQTTLHRN | 176 | Q02078 | |
| IHSVQEPSSQPMEVG | 1626 | Q9C091 | |
| EQRGMFTVSDHPPEQ | 141 | O95613 | |
| IQQSRVPHGRIMTPS | 241 | O15265 | |
| APMISNQRVTGPSHF | 211 | Q9UHB4 | |
| MGRVPRNHDSSQPTT | 191 | Q9H7P6 | |
| DHSVSQPIMVQRRPG | 181 | Q14671 | |
| THTARPPSMQVTIED | 6351 | Q5VST9 | |
| DQPTQTVVMHRTEPT | 836 | Q99613 | |
| SHPNSSMPGSREVQI | 731 | P36888 | |
| SMPGSREVQIHPDSD | 736 | P36888 | |
| NTSQATLGPEHLMPS | 191 | P32927 | |
| QAPTSPPRMTVHEGQ | 166 | Q969P0 | |
| MTPGVVHASPPQSQR | 1 | P09565 | |
| PVMSRSHSVVQQPES | 826 | Q96AV8 | |
| PSESIVVPGNTRMVH | 1976 | Q99715 | |
| SHQSSMPTRNGTQPP | 226 | Q9UBP9 | |
| VSQTGPVHAPIFTMS | 421 | Q12906 | |
| QRTSPTNPHQHMAVG | 301 | Q8IZC6 | |
| GPLAVVMVATNTPHS | 76 | Q8WWB7 | |
| QNTSLPMQGVAPTTH | 236 | Q53TQ3 | |
| PMQGVAPTTHTIAQA | 241 | Q53TQ3 | |
| STRMNILGSQSPLHP | 466 | Q13322 | |
| PMRHQILPGNTDSAE | 816 | Q02388 | |
| HTNTNGNSEPLVMPE | 796 | Q9Y4K1 | |
| HETTQPDMSSPGVFN | 71 | Q6ZVF9 | |
| VVMAASPGSLHSPQQ | 266 | Q03060 | |
| NSGLSMESIHVPDPV | 436 | Q96RP9 | |
| NPSSSRAHSPMIAVG | 171 | Q96EE3 | |
| PVTDDLQMAQGPSSH | 111 | Q5FWE3 | |
| IHHTTVVQPNGMPAT | 116 | A1KXE4 | |
| MTASEPLSQVSRGHP | 1306 | O94851 | |
| SHQSVSPGGTTMTPV | 536 | Q12889 | |
| MEPHAPSRGQAESST | 376 | Q86X27 | |
| PMGTNAVTSHLNQSP | 221 | P32243 | |
| VTTTQPHAGQPMDST | 21 | Q6P0A1 | |
| MHGTPRANLNSAPQS | 291 | Q8N2Y8 | |
| DIQTTRSNGMNPIHP | 431 | Q5VT97 | |
| PSTTSVHVQQGPQTM | 271 | Q4G112 | |
| QAPHQPTERTGRSEM | 501 | O95425 | |
| GIRTNVVTMPTAHPR | 1016 | Q13428 | |
| TPSPTTDLHSGLQMR | 211 | Q9H4M7 | |
| NSPMRNPVHSHIGAT | 121 | Q9HCM1 | |
| VMVNSTDPHGLPNTS | 46 | Q14916 | |
| PHNGSSEATLPAQMS | 146 | P50479 | |
| AQAATGTIMDPHSPE | 966 | P58107 | |
| TVNTASRMESHGLPN | 511 | O75343 | |
| PHATMTQQGNLDSPS | 1351 | Q8IVL1 | |
| MGPHSRASQVAPETT | 46 | A8MTI9 | |
| SVHSNMGLPTPQTFR | 111 | Q96LK8 | |
| GHLTPSSQMSSRPQE | 246 | Q9ULL8 | |
| TRMRQIASDSPHASP | 391 | Q9HCD6 | |
| ADTQGMSIPAQPHAS | 1776 | Q9UPS6 | |
| MSIPAQPHASTRAGS | 1781 | Q9UPS6 | |
| MTEILHPSSQAPNGV | 151 | P56182 | |
| RARTHTNVMNATSPP | 396 | Q8TBZ3 | |
| MDKHGQTVSPQSVPT | 251 | Q2Y0W8 | |
| TQPPVMPTTKHSRAQ | 641 | A1L4H1 | |
| MDLQTPDSHLRQTTP | 386 | Q53GL0 | |
| VAMASRPSQPTHVNV | 11 | Q3YBM2 | |
| QAMERATQEPSEHGP | 441 | Q8WZ75 | |
| QASQNRHSMEISPPV | 316 | Q7Z6J0 | |
| PNMSSTPAHEVGRRT | 876 | P55201 | |
| QNVPSRSGLPHMHSQ | 926 | Q9NRA8 | |
| QAESHSGPLNSMIPV | 4841 | Q8IVF2 | |
| LPHISTARSPQQVMG | 206 | Q9H6Q4 | |
| QANHPLTVPSSVVMG | 71 | Q8WZ69 | |
| GPSHVSMQQTAPNTL | 126 | O75177 | |
| EGNPPTELTQSQMLH | 641 | Q16620 | |
| TSGHQPSSVLRSPAM | 486 | Q9Y6X2 | |
| IAPIHSSAQAMSPTQ | 691 | Q9NRJ4 | |
| RSGPSPHQQAIVTAM | 486 | Q8IXK0 | |
| HRVEMPRQNSDPTSE | 631 | Q9UKE5 | |
| HKQPSGMNISRQSPT | 1111 | Q6ZU65 | |
| SQSMPLTPHQAVPSG | 181 | P15622 | |
| MDHLPTTTATPNQTV | 286 | Q9Y548 | |
| PGNASITISHMQPAD | 96 | Q86XK7 | |
| SSAVNITSPMNIGHP | 431 | Q14119 | |
| SSPHLTSQRPVDMVQ | 3486 | Q96T58 | |
| GNMVASHPIAASTPE | 351 | Q9NXL6 | |
| HMQLPSVPTQGRALT | 101 | Q6ZMY3 | |
| LHSPSSPRVEAQNEM | 151 | Q96A56 | |
| NVHNMTPATSPIGAS | 56 | O95155 | |
| QMPDTPSDLVRHTTT | 816 | Q5SVQ8 | |
| LRAPTQVTVSPETHM | 6 | Q3SY52 | |
| SAQKHRPTDSPEMNG | 196 | Q6ZV73 | |
| MRLSEPVPQTNAHES | 651 | P19174 | |
| NSSRVHQPTGMNQAP | 131 | Q8IYU4 | |
| PEVTQTPSHQVTQMG | 21 | A0A1B0GX68 | |
| MAETSPEPSGQLVVH | 1 | O43167 | |
| VTDSVHNINFMPGPS | 556 | O43167 | |
| AVPMETGVTQTPRHL | 16 | A0A589 | |
| SPTSRPTEDQIMHAG | 576 | Q9BRH9 | |
| RGTRVAVSSPMSQHQ | 1326 | Q9ULD9 | |
| PDNGSPAMTHRNLTS | 241 | Q9Y6R1 | |
| VRFHPSNPNMVVSGS | 176 | Q96FK6 | |
| VNISDQTMHSIPTSP | 531 | Q9HAU0 | |
| QTVPSLVHSTFQSMP | 701 | O15016 | |
| NSEVPMHRSAPSQTT | 51 | Q8NG27 | |
| AVPMETGVTQTPRHL | 16 | A0A539 | |
| QRKQNTSRPPSMHVD | 1641 | Q69YN4 | |
| QRTRSLPVHTSPQNM | 661 | Q9UPU9 | |
| MAAEIHSRPQSSRPV | 1 | Q8IWB7 | |
| SSTRHTSVVMLTPNP | 56 | Q6UXF1 | |
| VATTPLGPEHMAQAS | 86 | Q96T25 | |
| NRETQSPPSLQHSMS | 881 | Q9BYP7 | |
| SAPTGHTFSVMVTQP | 536 | Q8IYS2 | |
| HMSGPNELSTPSSDQ | 1551 | Q9NR99 |